serine protease inhibition (17) and alternate substrate inhibitors of cholesterol eastrase (18) . In view of all these observations, we report here in on the use of 2-amino-4,5,6,7--tetrahydrobenzo [b] thiophene derivatives (1a,b) (19) in the synthesis of novel benzo [b] thienopyrimidine derivatives. The systemic anti-depressant, sedative or analgesic activities of the newly synthesized compounds were also investigated.
EXPERIMENTAL

Synthetic methods, analytical and spectral data
Melting points were determined on an electrothermal apparatus (Büchi 535, Switzerland) in an open capillary tube and are uncorrected. Elemental analyses were determined on a Yanaco CHN Corder elemental analyzer (Japan). IR spectra (n cm -1 ) were recorded in KBr pellets on a PA-9721 IR spectrophotometer (Shimadzu, Japan). 1 H NMR and 13 C NMR spectra were obtained on a Jeol 300 MHz (Japan) spectrometer in DMSO--d 6 as solvent, using TMS as internal reference and chemical shifts (d) are expressed in ppm. Mass spectra were recorded on Kratos (75e V) MS equipment (Germany). Elemental analyzes were performed on a Yanaco CHN Corder elemental analyzes (Japan).
The analytical and spectral data of the newly synthesized products are presented in Tables I and II , respectively. The pharmacological data are given in Tables III, IV and V. Compounds 2a and 2b were synthesized according to our recently published work (20) .
3-Cyano-2-(N-ethoxycarbonylthiouryl)-4,5,6,7-tetrahydrobenzo[b]thiophene (2a) and ethyl 2-(N-ethoxycarbonylthiouryl)-4,5,6,7-tetrahydrobenzo[b]thiophen-3-carboxylate (2b)
General procedure. -To a solution of either 1a (1.78 g, 0.01 mol) or 1b (2.25 g, 0.01 mol) in 1,4-dioxan (30 mL), ethoxycarbonyl isothiocyanate (1.31 g, 0.01 mol) [prepared by adding ammonium isothiocyanate (0.01 mol) to a solution of ethyl chloroformate (0.01 mol) in 1,4-dioxan (20 mL) and heating for 1/2 h followed by isolation of the byproduct, ammonium chloride] was added. The whole reaction mixture, in each case, was stirred at room temperature overnight and the solid product formed upon pouring onto ice/water was collected by filtration to give either 2a or 2b, crystallized from acetic acid. 6,7,8,9-tetrahydrobenzo[b] thieno [2,3-d] pyrimidin -2-carboxylate (3a) and ethyl 1-oxo-3-thioxo-4 [H]- 6,7,8,9-tetrahydrobenzo[b] thieno [2,3- 
Ethyl 1-imino-3-thioxo-4[H]-
General procedure. -A suspension of either 2a (3.09 g, 0.01 mol) or 2b (3.56 g, 0.01 mol) in sodium ethoxide (0.01 mol) [prepared by dissolving sodium metal (0.23 g, 0.01 mol) in absolute ethanol (40 mL)] was heated in a boiling water bath for 6 h and then left to cool. The solid product, formed upon pouring onto ice/water containing hydrochloric acid (to pH = 6), was collected by filtration to give either 3a, crystallized from 1,4-dioxane or 3b, crystallized from ethanol. -4,5,6,7-tetrahydrobenzo[b] bath (140°C) for 1 h. Then, it was left to cool and the remaining product was triturated with diethyl ether and the formed solid product was collected by filtration to give either 4a or 4b, crystallized from acetic acid. 02 mol) in absolute ethanol (60 mL)] was heated in a boiling water bath for 12 h. The solid product formed upon pouring onto ice/water containing hydrochloric acid (till pH 6) was collected by filtration to give either 5a or 5b, crystallized from DMF.
3-Cyano-2-(N-phenylaminocarbonylthiourayl
Method B. -To the dry solid of either 3a (3.09 g, 0.01 mol) or 3b (3.10 g, 0.01 mol), aniline oil (0.94 g, 0.01 mol) was added. It was reaction mixture was heated in an oil bath (140°C) for 1 h. It was left to cool and the remaining product was triturated with diethyl ether and the formed solid product was collected by filtration. [2,3-d] pyrimidine (7a) and 1-oxo-2-phenylamino-carbonyl-3-(ethylacetatosulfyl) -6,7,8,9-tetrahydrobenzo[b] thieno [2,3- 
General procedure. -To a solution of either 5a (3.56 g, 0.01 mol) or 5b (3.57 g, 0.01 mol) in 1,4-dioxane (40 mL), either w-bromoacetophenone (2.0 g, 0.01 mol) or ethyl chloroacetate (1.22 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 2 h, then poured onto ice/water containing a few drops of sodium hydroxide (to pH 6) and the formed solid product was collected by filtration to give either 6a, 6b, 7a or 7b, crystallized from 1,4-dioxane.
3-Hydrazino-2-phenylaminocarbonyl-1-imino-6,7,8,9-tetrahydrobenzo[b]thieno[2,3-d]pyrimidine (8a), 3-phenylhydrazino-2-phenylaminocarbonyl-1-imino-6,7,8,9-tetrahydrobenzo[b]thieno [2,3-d]pyrimidine (8b), 3-hydrazino-2-phenylaminocarbonyl-1-oxo-6,7,8,9-tetrahydrobenzo[b] thieno[2,3-d]pyrimidine (8c) and 3-phenylhydrazino-2-phenylaminocarbonyl-1-oxo-6,7,8,9-tetrahydrobenzo[b]thieno[2,3-d]pyrimidine (8d)
General procedure. -To a solution of either 7a (4.42 g, 0.01 mol) or 7b (4.43 g, 0.01 mol) in 1,4-dioxane (40 mL), either hydrazine hydrate (0.5 g, 0.01 mol) or phenylhydrazine (1.08 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 6 h, then poured onto ice/water containing hydrochloric acid (to pH 6) and the formed solid product was collected by filtration to give either 8a or 8b, crystallized from 1,4-dioxane or 8c or 8d, crystallized from DMF. 
Animals
Swiss albino mice of either sex, weighing 20-25 g, aged 6-8 weeks, were supplied by the Animal House at National Research Centre (Giza, Egypt). Animals were maintained under 12/12 h light/dark cycle at 20 ± 2 and fed the standard laboratory diet and water ad libitum. In accordance with the recommendations for the proper care and use of laboratory animals (NIH publication No. 85-23, revised 1985), groups of 6 mice for group were used in all experiments.
Screening for antidepressant activity
Porsolt's forced-swimming test. -Each mouse was placed individually in a glass cylinder (diameter 12 cm, height 24 cm) filled with water to a height of 12 cm. Water temperature was maintained at 22-23°C. The animal was forced to swim for 6 min and the duration of immobility was measured. The mouse was considered to be immobile when it stopped struggling and moved only to remain floating in water, keeping its head above water. The floating time, which was the measure of despair (21), was recorded 60 min after treatment with each drug (15 or 30 mg kg -1 , i.p.), saline or imipramine (15 mg kg -1 , i.p.). Test compounds were dissolved using a few drops of Tween 80 and further dilutions were done using saline to get the necessary doses. The negative control was the vehicle solution (Tween 80 in saline).
Screening for sedative effect
Mice were observed in a commercially available motor activity apparatus (Ugo Basel, Italy) in which locomotor and exploratory activity could be monitored. In these experiments, each mouse was intraperitoneally injected with the drug (30 mg kg -1 ) and 30 min later it was placed in the activity monitor in which activity was monitored for 6 min.
Screening for analgesic effect
Acetic acid-induced writhing was performed for separate groups of 6 mice each, to which i.p. vehicle, compounds 2a, 3a, 5b, 6a and 8b (15 and 30 mg kg -1 ) or indomethacin were administered (20 mg kg -1 ). After 30 min pretreatment interval, an i.p. injection of 0.6% acetic acid was administered (22) . Each mouse was then placed in an individual clear plastic observational chamber and the total number of writhes (abdomen constriction, trunk twisting and extension of hind legs) made by each mouse was counted for 30 min after acetic acid administration.
Statistics
Data are presented as mean ± SEM. Data were analyzed by ANOVA followed by the Duncan and multiple group comparison test.
RESULTS AND DISCUSSION
Chemistry
The reaction of 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene derivative 1a,b with ethoxycarbonylisothiocyanate in 1,4-dioxane at room temperature gave the N-ethoxycarbonylthiourea derivatives 2a and 2b, respectively. The structures of compounds 2a,b were based on analytical and spectral data. Thus, the 1 H NMR spectrum of 2a showed the presence of a triplet at d 1.61 ppm corresponding to the ester CH 3 group, a multiplet at d 2.14-2.16 and 2.23-2.26 ppm corresponding to the four CH 2 groups of cyclohexene The reaction of 2a,b with aniline in an oil bath (at 140°C) gave the anilide derivatives 4a and 4b, respectively. Structures of compounds 4a,b were based on the obtained analytical and spectral data (see experimental section). In the reaction of 2b, aniline reacts with the ethyl N-carboxylate rather than the ethyl carboxylate group attached to C-thiophene based on the cyclization of 4b into 5b via ethanol elimination. Moreover, formation of the same cyclized product via another reaction route was noted. Thus, compounds 4a and 4b underwent ready cyclization when heated in sodium ethoxide/ethanol solution in a boiling water bath to give the 4,5,6,7-tetrahydrobenzo[b]thieno[2,3-d]-pyrimidine derivatives 5a and 5b, respectively. Structures of the latter products were established on the basis of analytical and spectral data and on their synthesis using another reaction route. Thus, the reaction of either 3a or 3b with aniline oil at 140°C gave the same products 5a and 5b, respectively (m.p., mixed m.p. and fingerprint IR spectrum) (Scheme 1).
The reaction of either compound 5a or 5b with w-bromoacetophenone in 1,4-dioxane gave the thioether-tetrahydrobenzo[b]thieno [2,3-d] pyrimidine derivatives 6a and 6b, respectively. Structures of the latter products were based on analytical and spectral data. On the other hand, the reaction of either 5a or 5b with ethyl chloroacetate gave the thioether derivatives 7a and 7b, respectively. The spectral data of the latter are consistent with the proposed structures (Tables I and II) . The reaction of either compound 7a or 7b with either hydrazine hydrate or phenylhydrazine afforded the corresponding 2-hydrazino-4,5,6,7-tetrahydrobenzo[b]thieno [2,3-d] pyrimidine derivatives 8a-d, respectively (Scheme 2). The analytical and spectral data of the latter products agree well with the proposed structures (Tables I and II) .
Screening for antidepressant activity
After 60 min of i.p. administration, some compounds (2a, 3a and 5b) showed mild, non-significant antidepressant activity at high doses and were found active, compared with negative control group. The other compounds failed to display antidepressant properties in the swimming test (Table III) . 
Screening for sedative activity
No sedative effect could be observed in mice treated with compounds 2a, 5b, 6a and 8b; even more exploratory movements compared to the saline treated group were observed (Table IV) .
All tested compounds at the two doses (15 acetic acid in mice (Table V) . Compound 2a was the most potent in this respect, inhibiting the number of abdominal writhes by 97.3% at high dose (30 mg kg -1 ), compared to saline as the negative control group. Meanwhile, compounds 6a, 3a and 5b at high doses inhibited the number of abdominal writhes by 74.7, 71.7 and 70.4%, respectively. These compounds, at low and high doses, were even more potent than indomethacin in this respect.
From the structure-activity relationship viewpoint, the thiourea tetrahydrobenzo-[b]thiophene derivative 2a has the strongest antidepressant and analgesic activity. Replacement of ethoxycarbonylthiouryl side chain with fused pyrimidine moiety decreased these activities in the other compounds. The presence of benzoylmethylsulphide side chain attached to pyrimidine moiety in compound 6a increased its activity as analgesic agent.
CONCLUSIONS
In this study, we have described efficient synthesis of novel benzo[b]thienopyrimidine derivatives derived from the thiourea derivatives of tetrahydrobenzo[b]thiophenes 2a and 2b. The newly synthesized thiophene derivatives 2a, 3a, 5b, 6a and 8b showed mild antidepressant and analgesic activity of various intensities. However, compound 2a had the strongest antidepressant and analgesic activity. Compounds 2a, 6a, 3a and 5b, as analgesic agents, at low and high doses, were more potent than indomethacin.
